Frederick R. Appelbaum

78.2k citations
595 papers · 42.6k indexed · 15 hit papers · h-index 105

Impact in

  • Hematology top 0.01%
    • Acute Myeloid Leukemia Research
    • Hematopoietic Stem Cell Transplantation
    • Chronic Myeloid Leukemia Treatments
  • Genetics top 0.02%
    • Chronic Lymphocytic Leukemia Research
    • Myeloproliferative Neoplasms: Diagnosis and Treatment

Papers in

    • Acute Myeloid Leukemia Research 322
    • Hematopoietic Stem Cell Transplantation 286
    • Chronic Myeloid Leukemia Treatments 83
    • Multiple Myeloma Research and Treatments 43
    • Chronic Lymphocytic Leukemia Research 55
    • Myeloproliferative Neoplasms: Diagnosis and Treatment 39

Frederick R. Appelbaum

589 papers receiving 41.6k citations

Hit Papers

Cord-Blood Transplantation in Patients with Minimal Residual Disease 2016 · 284 citations
284199320262004201550010001.5k2.0k

Peers

Frederick R. Appelbaum
Comparison fields: 5 of 163
  • Hematology 30.9k
  • Genetics 8.9k
  • Transplantation 1.3k
  • Oncology 10.1k
  • Public Health, Environmental and Occupational Health 10.6k
Replace H. Joachim Deeg with:
H. Joachim Deeg United States
Daniel J. Weisdorf United States
Sergio Giralt United States
Stephen J. Forman United States
Hillard M. Lazarus United States
Gèrard Socié France
Gerhard Ehninger Germany
Dietger Niederwieser Germany
David G. Maloney United States
CD Buckner United States
Frederick R. Appelbaum relative to H. Joachim Deeg United States H. Joachim Deeg's profile →
Citations per field
00.5×1.5×2.2×
H. Joachim Deeg · 1×
Citations per year

Countries citing papers authored by Frederick R. Appelbaum

Since Specialization
Citations

This map shows the geographic impact of Frederick R. Appelbaum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frederick R. Appelbaum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frederick R. Appelbaum more than expected).

Fields of papers citing papers by Frederick R. Appelbaum

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frederick R. Appelbaum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frederick R. Appelbaum. The network helps show where Frederick R. Appelbaum may publish in the future.

Co-authors

The 25 scholars most cited alongside Frederick R. Appelbaum, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Frederick R. Appelbaum Line = papers co-authored together Frederick R. Appelbaum links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20244
2 20214
3 20201
4 20191
5 20171
6 201596
7 2015258
8 201511
9 201520
10 20142
11
Addition of gemtuzumab ozogamicin to induction chemotherapy in adult patients with acute myeloid leukaemia: a meta-analysis of individual patient data from randomised controlled trials
Hit paper breakdown →
2014479
12 201388
13
Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria
Hit paper breakdown →
2011453
14 2011244
15 2010311
16 201081
17
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
Hit paper breakdown →
20092350
18 200871
19 2007256
20 2007300

About Frederick R. Appelbaum

Frederick R. Appelbaum is a scholar working on Hematology, Genetics, Transplantation, Public Health, Environmental and Occupational Health and Oncology, having authored 595 papers that have together received 42.6k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (322 papers), Hematopoietic Stem Cell Transplantation (286 papers), Acute Lymphoblastic Leukemia research (171 papers), Chronic Myeloid Leukemia Treatments (83 papers), Chronic Lymphocytic Leukemia Research (55 papers), Lymphoma Diagnosis and Treatment (53 papers), Multiple Myeloma Research and Treatments (43 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (39 papers). The work is most often cited by research in Hematology (30.9k citations), Genetics (8.9k citations), Transplantation (1.3k citations), Oncology (10.1k citations) and Public Health, Environmental and Occupational Health (10.6k citations). Frederick R. Appelbaum has collaborated with scholars based in United States, South Africa and Canada. Frequent co-authors include Rainer Storb, Cheryl L. Willman, Paul J. Martin, Kenneth J. Kopecky, Elihu H. Estey, Marilyn L. Slovak, H. Joachim Deeg, Barry E. Storer, Richard A. Larson and David R. Head. Their work appears in journals such as Blood, Biology of Blood and Marrow Transplantation, Journal of Clinical Oncology, British Journal of Haematology and Transplantation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026